Kessler RC, McGonagle KA, Zhao S.
et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders
in the US. Arch Gen Psychiatry.1994;51:8-19.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth
Edition, Text Revision. Washington, DC: American Psychiatric Association; 1994.
Norton GR, Cox BJ, Malan J. Nonclinical panickers: a critical review. Clin Psychol Rev.1992;12:121-139.
Myers JK, Weissman MM, Tischler GL.
et al. Six-month prevalence of psychiatric disorders in three communities:
1980-1982. Arch Gen Psychiatry.1984;41:959-967.
Weissman MM, Bland RC, Canino GJ.
et al. The cross-national epidemiology of panic disorder. Arch Gen Psychiatry.1997;54:305-309.
Black B, Robbins D. Panic disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry.1990;29:36-44.
Crowe RR, Noyes R, Pauls DL, Slymen D. A family study of panic disorder. Arch Gen Psychiatry.1983;40:1065-1069.
Torgersen S. Genetic factors in anxiety disorders. Arch Gen Psychiatry.1983;40:1085-1089.
Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. Panic disorder in women: a population-based twin study. Psychol Med.1993;23:397-406.
Kagan J, Reznick JS, Clarke C, Snidman N, Garcia-Coll C. Behavioral inhibition to the unfamiliar. Child Dev.1984;55:2212-2225.
Kagan J, Reznick JS, Snidman N. The physiology and psychology of behavioral inhibition in children. Child Dev.1987;58:1459-1473.
Rosenbaum JF, Biederman J, Gersten M.
et al. Behavioral inhibition in children of parents with panic disorder and
agoraphobia: a controlled study. Arch Gen Psychiatry.1988;45:463-470.
Hirshfeld DR, Rosenbaum JF, Biederman J.
et al. Stable behavioral inhibition and its association with anxiety disorder. J Am Acad Child Adolesc Psychiatry.1992;31:103-111.
Tweed JL, Schoenbach VJ, George LK, Blazer DG. The effects of childhood parental death and divorce on six-month history
of anxiety disorders. Br J Psychiatry.1989;154:823-828.
Stein MB, Walker JR, Anderson G.
et al. Childhood physical and sexual abuse in patients with anxiety disorders
and in a community sample. Am J Psychiatry.1996;153:275-277.
Lipsitz JD, Martin LY, Mannuzza S.
et al. Childhood separation anxiety disorder in patients with adult anxiety
disorders. Am J Psychiatry.1994;151:927-929.
Pitts Jr FN, McClure Jr JN. Lactate metabolism in anxiety neurosis. N Engl J Med.1967;277:1329-1336.
Liebowitz MR, Fyer AJ, Gorman JM.
et al. Lactate provocation of panic attacks, I: clinical and behavioral findings. Arch Gen Psychiatry.1984;41:764-770.
Charney DS, Heninger GR, Gbreier A. Noradrenergic function in panic anxiety: effects of yohimbine in healthy
subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry.1984;41:751-763.
Gorman JM, Papp LA, Coplan JD.
et al. Anxiogenic effects of CO2 and hyperventilation in patients with panic
disorder. Am J Psychiatry.1994;151:547-553.
Bradwejn J, Koszycki D, Shriqui C. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Arch Gen Psychiatry.1991;48:603-610.
Pyke RE, Greenberg HS. Norepinephrine challenges in panic patients. J Clin Psychopharmacol.1986;6:279-285.
Abelson JL, Weg JG, Nesse RM, Curtis GC. Neuroendocrine responses to laboratory panic. Psychoneuroendocrinology.1996;21:375-390.
Rainey Jr JM, Aleem A, Ortiz A, Yeragani V, Pohl R, Berchou R. A laboratory procedure for the induction of flashbacks. Am J Psychiatry.1987;144:1317-1319.
Southwick SM, Krystal JH, Morgan A.
et al. Abnormal noradrenergic function in posttraumatic stress disorder. Arch Gen Psychiatry.1993;50:266-274.
Facchinetti F, Romano G, Fava M, Genaazzani AR. Lactate infusion induces panic attack in patients with premenstrual
syndrome. Psychosom Med.1992;54:288-296.
Kent JM, Papp LA, Martinez JM.
et al. Specificity of panic response to CO2 inhalation in panic disorder. Am J Psychiatry.2001;158:58-67.
LeDoux JE, Cicchetti P, Xagoraris A, Romanski LM. The lateral amygdaloid nucleus. J Neurosci.1990;10:1062-1069.
Davis M. The role of the amygdala in fear and anxiety. Annu Rev Neurosci.1992;15:353-375.
Furmark T, Fisher H, Wik G, Larsson M, Fredrickson M. The amygdala and individual differences in human fear conditioning. Neuroreport.1997;8:3957-3960.
Gorman JM, Liebowitz MR, Shear KM. Panic and anxiety disorders. In: Michels R, Cavenar JO, Brodie H, eds. Psychiatry. New York, NY: Lippincott Co; 1994.
Stein MB, Shea CA, Uhde TW. Social phobic symptoms in patients with panic disorder: practical and
theoretical implications. Am J Psychiatry.1989;146:235-238.
Lepola U, Koponen H, Leinonen E. A naturalistic 6-year follow-up study of patients with panic disorder. Acta Psychiatr Scand.1996;93:181-183.
Schuckit MA, Hesselbrock V. Alcohol dependence and anxiety disorders: what is the relationship? Am J Psychiatry.1994;151:1723-1734.
Lesser IM, Rubin RT, Pecknold JC.
et al. Secondary depression in panic disorder and agoraphobia, I. Arch Gen Psychiatry.1988;45:437-443.
Ballenger JC. Panic disorder in primary care and general medicine. In: Rosenbaum JF, Pollack MH, eds. Panic Disorder
and Its Treatment. New York, NY: Marcel Dekker; 1998:1-36.
Gorman JM, Goetz RR, Fyer M.
et al. The mitral valve prolapse-panic disorder connection. Psychosom Med.1988;50:114-122.
Grunhaus L, Gloger S, Birmacher B. Clomipramine treatment for panic attacks in patients with mitral valve
prolapse. J Clin Psychiatry.1984;45:25-27.
Yellowless PM, Alpers JH, Bowden JJ, Bryant GD, Ruffin RE. Psychiatric morbidity in patients with chronic airflow obstruction. Med J Aust.1987;146:305-307.
Lydiard RB, Greenwald S, Weissman MM.
et al. Panic disorder and gastrointestinal symptoms: findings from the NIMH
Epidemiologic Catchment Area Project. Am J Psychiatry.1994;151:64-70.
Merikangas KR, Angst J, Isler H. Migraine and psychopathology: results of the Zurich cohort study of
young adults. Arch Gen Psychiatry.1990;47:849-853.
Kawachi I, Colditz GA, Ascherio A.
et al. Prospective study of phobic anxiety and risk of coronary heart disease
in men. Circulation.1994;89:1992-1997.
Kawachi I, Sparrow D, Vokonas PS, Weiss ST. Symptoms of anxiety and risk of coronary heart disease. Circulation.1994;90:2225-2229.
Gorman JM, Sloan R. Heart rate variability in depressive and anxiety disorders. Am Heart J.2000;140:77-83.
Mukerji V, Beitman BD, Alpert MA. Chest pain and angiographically normal coronary arteries: implications
for treatment. Tex Heart Inst J.1993;20:170-179.
Weissman MM, Klerman GL, Markowitz JS, Ouellette R. Suicidal ideation and attempts in panic disorder and attacks. N Engl J Med.1989;321:1209-1214.
Markowitz JS, Weissman MM, Ouellette R, Lish JD, Klerman GL. Quality of life in panic disorder. Arch Gen Psychiatry.1989;46:984-992.
Wolfe BE, Maser JD. Treatment of Panic Disorder: A Consensus Development
Conference. Washington DC: American Psychiatric Press; 1994.
Otto MW, Deckersbach T. Cognitive-behavioral therapy for panic disorder: theory, strategies
and outcome. In: Rosenbaum JF, Pollack MH, eds. Panic Disorder
and Its Treatment. New York, NY: Marcel Dekker; 1998:181-203.
Barlow DH. Anxiety and Its Disorders: The Nature and Treatment
of Anxiety and Panic. New York, NY: Guilford Press; 1988.
Barlow DH. Effectiveness of behavior treatment for panic disorder with and without
agoraphobia. In: Wolfe BE, Maser JD, eds. Treatment of Panic
Disorder: A Consensus Development Conference. Washington, DC: American
Psychiatric Press; 1994:105-120.
Agras WS, Leitenberg H, Barlow DH. Social reinforcement in the modification of agoraphobia. Arch Gen Psychiatry.1968;19:423-427.
Barlow DH, Craske MG, Cerney JA, Klosko JS. Behavioral treatment of panic disorder. Behav Ther.1989;20:261-282.
Craske MG, Brown TA, Barlow DH. Behavioral treatment of panic disorder: a two-year follow-up. Behav Ther.1991;22:289-304.
Brown TA, Barlow DH. Long-term outcome of cognitive behavioral, treatment of panic disorder. J Consult Clin Psychol.1995;63:754-765.
Klein DF. Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia.1964;5:397-408.
Sheehan DV, Ballenger J, Jacobson G. Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal
symptoms. Arch Gen Psychiatry.1980;37:51-59.
Papp LA, Gorman JM. Panic disorder and agoraphobia. In: Conn's Current Therapy. Philadelphia,
Pa: WB Saunders Co; 1990.
Ballenger JC, Burrows GD, DuPont Jr RL.
et al. Alprazolam in panic disorder and agoraphobia: results from a multicenter
trial, I: efficacy in short-term treatment. Arch Gen Psychiatry.1988;45:413-422.
Rosenbaum JF, Moroz G, Bowden CL. Clonazepam in the treatment of panic disorder with or without agoraphobia. J Clin Psychopharmacol.1997;17:390-400.
Charney DS, Woods SW. Benzodiazepine treatment of panic disorder: a comparison of alprazolam
and lorazepam. J Clin Psychiatry.1989;50:418-423.
Work Group on Panic Disorder. American Psychiatric Association.. Practice guideline for the treatment of patients with panic disorder. Am J Psychiatry.1998(suppl);155:1-34.
Black DW, Wesner R, Bowers W, Gabel J. A comparison of fluvoxamine, cognitive-therapy, and placebo in the
treatment of panic disorder. Arch Gen Psychiatry.1993:50:44-50.
Schneier FR, Leibowitz MR, Davies SO.
et al. Fluoxetine in panic disorder. J Clin Psychopharmacol.1990;10:119-121.
Wade AG, Lepola U, Koponen HJ, Pedersen V, Pedersen T. The effect of citalopram in panic disorder. Br J Psychiatry.1997;170:549-553.
Ballenger JC, Wheadon DE, Steiner M, Bushnell W, Gergel IP. Double-blind, fixed-dose, placebo-controlled study of paroxetine in
the treatment of panic disorder. Am J Psychiatry.1998;155:36-42.
Pohl RB, Wolkow RM, Clary CM. Sertraline in the treatment of panic disorder: a double-blind multicenter
trial. Am J Psychiatry.1998;155:1189-1195.
Mavissakalian M, Perel JM. Clinical experiments in maintenance and discontinuation of imipramine
therapy in panic disorder with agoraphobia. Arch Gen Psychiatry.1992;49:318-323.
Rickels K, Schweizer E, Weiss S, Zavodnick S. Maintenance drug treatment for panic disorder, II: short- and long-term
outcome after drug taper. Arch Gen Psychiatry.1993;50:61-68.
LeCrubier Y, Bakker A, Dunbar G, Judge R. A comparison of paroxetine, clomipramine and placebo in the treatment
of panic disorder. Acta Psychiatr Scand.1997;95:145-152.
Barlow DH, Gorman JM, Shear MK, Woods SW. Cognitive-behavioral therapy, imipramine, or their combination for
panic disorder. JAMA.2000;283:2529-2536.
Sheehan DV, Davidson J, Manschreck T, Van Wyck Fleet J. Lack of efficacy of a new antidepressant (bupropion) in the treatment
of panic disorder with phobias. J Clin Psychopharmacol.1983;3:28-31.
Goddard AW, Brouette T, Almai A.
et al. Early co-administration of clonazepam with sertraline. Arch Gen Psychiatry.2001;58:681-686.
Spiegel DA, Bruce TJ. Benzodiazepines and exposure-based cognitive behavior therapies for
panic disorder. Am J Psychiatry.1997;154:773-781.